Question 1

What is LOPJLB’s current signal on CRDF?

Accepted Answer

LOPJLB’s latest quantitative signal on Cardiff Oncology, Inc. (CRDF) is SELL in a CRISIS regime. Signals are updated daily.

Question 2

What market regime is CRDF in?

Accepted Answer

Cardiff Oncology, Inc. (CRDF) is currently classified in the CRISIS HMM market regime on LOPJLB.

Question 3

What does Cardiff Oncology, Inc. (CRDF) do?

Accepted Answer

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials …

Question 4

Where is Cardiff Oncology, Inc. based / listed?

Accepted Answer

Cardiff Oncology, Inc. is based in US, listed on NASDAQ.

Cardiff Oncology, Inc. (CRDF)

Key stats

Industry peers

Prediction markets

Company news